These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Christensen D; Trygstad T; Sullivan R; Garmise J; Wegner SE Am J Geriatr Pharmacother; 2004 Dec; 2(4):248-56. PubMed ID: 15903283 [TBL] [Abstract][Full Text] [Related]
25. Lower drug prices may trigger increase in cost of services. Schwartz R Contemp Longterm Care; 1991 Mar; 14(3):22, 76. PubMed ID: 10109431 [No Abstract] [Full Text] [Related]
26. Medicaid cost containment series: the Urban Institute reports. Pollak W Perspect Medicaid Manage; 1979 Apr; ():46-62. PubMed ID: 10297714 [No Abstract] [Full Text] [Related]
27. The consultant pharmacist's criteria for an inservice program in the long-term care facility. Catsban DC Hosp Pharm; 1985 Dec; 20(12):933. PubMed ID: 10274576 [No Abstract] [Full Text] [Related]
28. View from the other side: an interview with a pharmacist-surveyor. Interview with Jean Farley, RPh. Martin CM Consult Pharm; 2008 Jul; 23(7):520-4, 529. PubMed ID: 18764670 [TBL] [Abstract][Full Text] [Related]
29. Legal implications of the pharmacist's expanded clinical roles: a challenge to the clinical pharmacist's competencies. Moore RC; Mikeal RL; Brewer BF; Burton SF Contemp Pharm Pract; 1979; 2(3):132-5. PubMed ID: 10297530 [TBL] [Abstract][Full Text] [Related]
30. Principles of nursing home reimbursement. Deane RT Health Care Strateg Manage; 1985 Aug; 3(8):26-8. PubMed ID: 10300315 [No Abstract] [Full Text] [Related]
33. Medicaid payment rates, case-mix reimbursement, and nursing home staffing--1996-2004. Feng Z; Grabowski DC; Intrator O; Zinn J; Mor V Med Care; 2008 Jan; 46(1):33-40. PubMed ID: 18162853 [TBL] [Abstract][Full Text] [Related]
34. Role of a pharmacist in improving rational drug therapy as part of the patient care team. Smith WE Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008 [TBL] [Abstract][Full Text] [Related]
35. Perceived clinical significance of consultant pharmacist recommendations in the skilled nursing facility. Miller DA; Lucarotti RL; Vlasses PH; Krigstein DJ; McKercher PL Drug Intell Clin Pharm; 1980 Mar; 14(3):182-6. PubMed ID: 10246655 [TBL] [Abstract][Full Text] [Related]
36. Drug therapy review in nursing homes: proposed standards and guidelines. Lamy PP; Krug BH Contemp Pharm Pract; 1981; 4(3):125-31. PubMed ID: 10252149 [TBL] [Abstract][Full Text] [Related]
37. How states pay for long-term care facility services under Medicaid. Jazwiecki T Healthc Financ Manage; 1984 Apr; 38(4):76-80. PubMed ID: 10315531 [No Abstract] [Full Text] [Related]
38. Pharmacist-physician partnership reduces unwanted drug consequences. Levenson D Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):9-10, 12. PubMed ID: 13677339 [No Abstract] [Full Text] [Related]
39. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success. Levenson SA; Saffel D Consult Pharm; 2007 Jan; 22(1):71-82. PubMed ID: 17367254 [TBL] [Abstract][Full Text] [Related]
40. The devil's in the details: trading policy goals for complexity in medicaid nursing home reimbursement. Miller EA; Mor V; Grabowski DC; Gozalo PL J Health Polit Policy Law; 2009 Feb; 34(1):93-135. PubMed ID: 19234295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]